Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schneider-Gold

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Fortschritte Der Neurologie-Psychiatrie|January 28, 2004
[Myasthenia gravis: pathology, diagnosis and treatment]C Schneider-Gold, H-P Hartung
Schmerz (Berlin, Germany)|June 8, 2006
[Musculoskeletal pain as the most prominent feature in myotonic dystrophy type 2]A George, C Schneider-Gold, K Reiners, et al.
The Cochrane Database of Systematic Reviews|April 23, 2005
Corticosteroids for myasthenia gravisC Schneider-Gold, P Gajdos, K V Toyka, et al.
European Journal of Neurology|January 27, 2010
Side effects of anesthesia in DM2 as compared to DM1: a comparative retrospective studyL Kirzinger, A Schmidt, C Kornblum, et al.
European Journal of Neurology|April 18, 2007
Mitofusin 2 gene mutation (R94Q) causing severe early-onset axonal polyneuropathy (CMT2A)C Neusch, J Senderek, T Eggermann, et al.
Fortschritte Der Neurologie-Psychiatrie|July 9, 2016
[Radiation-Induced Radiculopathy with Paresis of the Neck and Autochthonous Back Muscles with Additional Myopathy]G Ellrichmann, C Lukas, I A Adamietz, et al.
Neurology|March 1, 2006
Outcome and effect of pregnancy in myotonic dystrophy type 2S Rudnik-Schöneborn, C Schneider-Gold, U Raabe, et al.
Neurology|February 13, 2003
Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathyC Schneider-Gold, M Beck, C Wessig, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2003
Neuroleptic malignant syndrome in Kufs' diseaseA Reif, M F Schneider, A Hoyer, et al.
The British Journal of Dermatology|July 21, 2019
Autoimmune radiculoplexus neuropathy under adjuvant nivolumab treatment of a female patient with melanomaT Gambichler, L Susok, M Fels, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Fortschritte Der Neurologie-Psychiatrie|January 28, 2004
[Myasthenia gravis: pathology, diagnosis and treatment]C Schneider-Gold, H-P Hartung
Schmerz (Berlin, Germany)|June 8, 2006
[Musculoskeletal pain as the most prominent feature in myotonic dystrophy type 2]A George, C Schneider-Gold, K Reiners, et al.
The Cochrane Database of Systematic Reviews|April 23, 2005
Corticosteroids for myasthenia gravisC Schneider-Gold, P Gajdos, K V Toyka, et al.
European Journal of Neurology|January 27, 2010
Side effects of anesthesia in DM2 as compared to DM1: a comparative retrospective studyL Kirzinger, A Schmidt, C Kornblum, et al.
European Journal of Neurology|April 18, 2007
Mitofusin 2 gene mutation (R94Q) causing severe early-onset axonal polyneuropathy (CMT2A)C Neusch, J Senderek, T Eggermann, et al.
Fortschritte Der Neurologie-Psychiatrie|July 9, 2016
[Radiation-Induced Radiculopathy with Paresis of the Neck and Autochthonous Back Muscles with Additional Myopathy]G Ellrichmann, C Lukas, I A Adamietz, et al.
Neurology|March 1, 2006
Outcome and effect of pregnancy in myotonic dystrophy type 2S Rudnik-Schöneborn, C Schneider-Gold, U Raabe, et al.
Neurology|February 13, 2003
Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathyC Schneider-Gold, M Beck, C Wessig, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2003
Neuroleptic malignant syndrome in Kufs' diseaseA Reif, M F Schneider, A Hoyer, et al.
The British Journal of Dermatology|July 21, 2019
Autoimmune radiculoplexus neuropathy under adjuvant nivolumab treatment of a female patient with melanomaT Gambichler, L Susok, M Fels, et al.
Pageof 2